Article Details
Retrieved on: 2024-06-15 08:49:50
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article highlights the FDA's recent actions, including updates on COVID-19 vaccines, AI in pharmacovigilance, and machine learning-enabled medical devices. These actions relate to machine learning through efforts to enhance drug safety and prescribing practices using AI. Tags reflect FDA's regulatory scope over healthcare technologies and policies.
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here